Acute myeloid leukemia in older patients: 6 questions asked and answered
ASH guidelines provide evidence-based recommendations. While an average 75-year-old in the United States can expect to live another dozen years, life expectancy for those…
Oncology
A Nurse’s Journey of Empathy and Compassion
Let’s call her Carol It was my first year as a nurse in a suburban Intensive Care unit. I worked the night shift and…
FDA issues caution for robot-assisted mastectomy
On Feb. 28, the FDA issued a caution for robot-assisted mastectomy, noting that it has not cleared or approved any robotically assisted surgical device…
Ovarian Cancer
A call to action for early detection and diagnosis. This article was provided to American Nurse Journal by Aspira Women’s Health and did not…
Mitigating melanoma
Melanoma, which was once thought to be uncommon, is the most serious type of skin cancer. It accounts for 75% of deaths associated with…
Standardizing handoff communication
Although adverse events can occur anytime during hospitalization, handoff communication is often the cause of avoidable adverse events. Miscommunication, care continuity disruption, critical data…
Tumor lysis syndrome
Tumor lysis syndrome is an oncologic emergency requiring diligent nursing care. Uric acid nephropathy from tumor lysis syndrome can cause acute renal failure.
Cancer immunotherapy update
Review of immune checkpoint inhibitor and CAR T-cell therapy adverse effects and treatments. Takeaways: The U.S. Food and Drug Administration has approved several immunotherapy…
Scientists can silence inflammatory gene responsible for a form of breast cancer
Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of breast cancer.…
My cancer journey
I’m a nurse. I’m not supposed to be a patient. I’m not supposed to get cancer. I have too much to do to add…
New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc was previously…
Study examines rate of cancer overdiagnosis in Australia
A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be attributed to…
Acute myeloid leukemia in older patients: 6 questions asked and answered
ASH guidelines provide evidence-based recommendations. While an average 75-year-old in the United States can expect to live another dozen years, life expectancy…
A Nurse’s Journey of Empathy and Compassion
Let’s call her Carol It was my first year as a nurse in a suburban Intensive Care unit. I worked the night…
FDA issues caution for robot-assisted mastectomy
On Feb. 28, the FDA issued a caution for robot-assisted mastectomy, noting that it has not cleared or approved any robotically assisted…
Ovarian Cancer
A call to action for early detection and diagnosis. This article was provided to American Nurse Journal by Aspira Women’s Health and…
Mitigating melanoma
Melanoma, which was once thought to be uncommon, is the most serious type of skin cancer. It accounts for 75% of deaths…
Standardizing handoff communication
Although adverse events can occur anytime during hospitalization, handoff communication is often the cause of avoidable adverse events. Miscommunication, care continuity disruption,…
Tumor lysis syndrome
Tumor lysis syndrome is an oncologic emergency requiring diligent nursing care. Uric acid nephropathy from tumor lysis syndrome can cause acute renal…
Cancer immunotherapy update
Review of immune checkpoint inhibitor and CAR T-cell therapy adverse effects and treatments. Takeaways: The U.S. Food and Drug Administration has approved…
Scientists can silence inflammatory gene responsible for a form of breast cancer
Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of…
My cancer journey
I’m a nurse. I’m not supposed to be a patient. I’m not supposed to get cancer. I have too much to do…
New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc…
Study examines rate of cancer overdiagnosis in Australia
A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.